statistiche ricercatore

Continente	#
NA - Nord America	558
AS - Asia	529
EU - Europa	301
SA - Sud America	104
AF - Africa	10
Continente sconosciuto - Info sul continente non disponibili	10
OC - Oceania	1
Totale	1.513

Nazione	#
US - Stati Uniti d'America	504
SG - Singapore	231
RU - Federazione Russa	143
CN - Cina	126
BR - Brasile	78
VN - Vietnam	69
IT - Italia	49
HK - Hong Kong	34
CA - Canada	33
BD - Bangladesh	23
GB - Regno Unito	22
FI - Finlandia	20
DE - Germania	17
MX - Messico	13
FR - Francia	12
IN - India	11
SE - Svezia	10
AR - Argentina	8
PL - Polonia	7
TR - Turchia	7
CO - Colombia	6
JP - Giappone	6
ES - Italia	5
ID - Indonesia	5
LT - Lituania	5
ZA - Sudafrica	4
AT - Austria	3
IQ - Iraq	3
CL - Cile	2
CR - Costa Rica	2
EC - Ecuador	2
EG - Egitto	2
IE - Irlanda	2
PE - Perù	2
PK - Pakistan	2
PY - Paraguay	2
UA - Ucraina	2
VE - Venezuela	2
AU - Australia	1
AZ - Azerbaigian	1
BB - Barbados	1
BY - Bielorussia	1
CU - Cuba	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
GE - Georgia	1
GT - Guatemala	1
GY - Guiana	1
IL - Israele	1
IR - Iran	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
LB - Libano	1
LK - Sri Lanka	1
MA - Marocco	1
ML - Mali	1
MY - Malesia	1
NL - Olanda	1
NP - Nepal	1
OM - Oman	1
PR - Porto Rico	1
RS - Serbia	1
TH - Thailandia	1
TN - Tunisia	1
UY - Uruguay	1
Totale	1.504

Nome	#
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction	208
Bridging Atrial and Ventricular Failure Through Biomarkers	204
Sudden Cardiac Death in Heart Failure: A 20-Year Perspective From a Mediterranean Cohort	202
Trajectories of Kidney Function in Heart Failure Over a 15-Year Follow-Up	170
Biomarkers of inflammation in heart failure: from risk prediction to possible treatment targets	158
Do we need to EVALUATE multiple biomarkers and/or the same biomarkers multiple times in patients with heart failure?	153
Reply to the letter regarding the article ‘Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines’	147
Empagliflozin in heart failure with preserved and mildly reduced ejection fraction: prognostic benefit confirmed with different endpoint definitions	141
Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction	130
Totale	1.513

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2024/2025	410	10	8	23	7	24	15	67	103	40	27	60	26
2025/2026	1.068	73	114	90	220	142	98	75	33	42	68	62	51
2026/2027	35	14	21	0	0	0	0	0	0	0	0	0	0
Totale													1.513